Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case

Dis Colon Rectum. 2008 Sep;51(9):1425-6. doi: 10.1007/s10350-008-9282-8. Epub 2008 May 10.

Authors

Miriam Koopman¹, Erik W Muller, Cornelis J A Punt

Affiliation

¹ Department of Medical Oncology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

PMID: 18470563
DOI: 10.1007/s10350-008-9282-8

No abstract available

Publication types

Case Reports

MeSH terms

Angiogenesis Inhibitors / adverse effects*
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal, Humanized
Antihypertensive Agents / therapeutic use
Bevacizumab
Colorectal Neoplasms / drug therapy
Humans
Male
Middle Aged
Posterior Leukoencephalopathy Syndrome / chemically induced*
Posterior Leukoencephalopathy Syndrome / diagnostic imaging
Posterior Leukoencephalopathy Syndrome / drug therapy*
Radiography

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antihypertensive Agents
Bevacizumab